Physician profile
Phillip Pham
NPI 1265633341
$5,270.00
in general payments reported to CMS, 2019-2025
40 companies · $677 in 2025
The $677 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $989 · 2020: $343 · 2021: $454 · 2022: $534 · 2023: $1,545 · 2024: $727 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,689 · Travel and Lodging: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,689.10 |
| Travel and Lodging | $260.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,309.85 | 2021-2025 | |
| Medtronic, INC. | $426.15 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $340.76 | 2019-2024 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Collegium Pharmaceutical, INC. | $320.72 | 2020-2025 | Belbuca, Xtampza |
| Amgen INC. | $290.67 | 2019-2022 | |
| Spr Therapeutics, INC | $260.87 | 2023 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $182.52 | 2019-2025 | |
| Pfizer INC. | $177.72 | 2020-2025 | |
| Biohaven Pharmaceuticals, INC. | $162.39 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $161.68 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $145.56 | 2019-2024 | Uzedy |
| Lundbeck LLC | $126.47 | 2022-2023 | Vyepti |
| Amniox Medical, INC. | $109.80 | 2019 | |
| Axsome Therapeutics, INC. | $107.37 | 2025 | Symbravo |
| Impel Pharmaceuticals INC. | $96.94 | 2023 | Trudhesa |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.